1Bulow B, Hagmar L, Eskils.son J, et al. Hypopituitary females have a high incidence of cardiovascular morbidity and increased prevalence of cardiovascular risk factors [J ]. J Clin Endocrinol Metab,2000, 85 : 574 - 584.
2Cummings MH, Christ E, Umpleby AM, et al. Anormalities of very low density lipoprotein apolipoprotein B- 100 metabolism contribute to the dyslipidemia of adult growth hormone defieieney[J ]. J Clin Endocrinol Metab , 1997, 82:2010 -2013.
3Evans LM, Davies JS, Goodfellow J, et al. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency [ J ].Clin Endocrinol, 1999,50:457 - 464.
4Degerblad M, Bengtsson BA, Brmnert M, et al. Reduced bone mineral density in adults with growth hormone deficiency: Increased bone turnover during 12 months of GH substitution therapy[J]. Eur J Endocrinol, 1995, 133:180-188.
5Attanasio AF, Lamberts SW J, Matranga AMC, et al. Adult growth hormone deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment[J ]. J Clin Endocrinol Metab, 1997, 82:85 - 88.
6Ghigo E, Aimaretti G, Gianotti L, et al. New approach to the diagnosis of growth hormone deficiency in adults [ J ]. Eur J Endocrinol, 1996,134: 352 - 356.
7Popovic V, Leal A, Micic D, et al. GH- releasing hormone and GH- releasing peptide - 6 for diagnostic testing in GH - deficient adults[J ]. Lancet, 2000, 356 : 11137 - 1142.
8Hilding A, Hall K, Wivall - Helleyd Ⅱ , et al. Serum levels of insulin- like growth factor Ⅰ in 152 patients with growth hormone deficiency, aged, 19- 82 years, in relation to those in healthy subjects[J]. J Clin Endocinol Metab , 1999, 84:2013 -2019.
9Aimaretti G, Comeli G, Razzore P, et al. Usefulness of IGF- I assay for the diagnosis of GH deficiency in adults[J ]. J Endocrinol Invest , 1998,21 : 506 - 511.
10Vance ML, Manras N. Growth hormone therapy in adults and children[J]. N Engl J Med, 1999,341 : 1206.
2Consensus guidelines for the diagnosis and treatment of adults with GH deficiency Ⅱ:a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology,Lawson Wilkins Society,European Society of Endocrinology,Japan Endocrine Society,and Endocrine Society of Australia.Ho KK;2007 GH Deficiency Consensus Workshop Participants.Eur J Endocrinol,2007,157:695-700.
4Kim HJ,Kwon SH,Kim SW,et al.Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.Horm Res,2001,56:117-123.
5Fisker S,Jorgensen JO,Orskov H,et al.L-arginine and insulin-tolerance tests in the diagnosis of adult growth hormone deficiency:influence of confounding factors.Clin Endocrinol(Oxf),1998,48:109-115.
6Svensson J,Johannsson G,Bengtsson BA.Body composition and quality of life as markers of the efficacy of growth Hormone replacement therapy in adults.HormRes,2001,55(suppl2):S55-60.
7Maghnie M,Cavigioli F,Tinelli C,et al.GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.J Clin Endocrinol Metab,2002,87:2740-2744.
8Cairo M C, Thrasher A, Mavilio F. The future of gene therapy.Nature, 2004,427 : 779 - 781.
9Vance M L, Mauras N. Growth hormone therapy in adults and Children. Drug Therapy, 1999,341(16) : 1206 - 1216.
10Tachibana K, Suwa S. A study on the hight of children with Achondrop-lasia based on a nationwide survey. Annu Rep Grouth Sci Assoc, 1993,17(1):431 -444.
